Beat Roth - ARCHIVE

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


99 publications

Sous presse | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 1999 |
Sous presse
 
WITHDRAWN: The benefit of adopting Microultrasound in the prostate cancer imaging pathway : A lesion-by-lesion analysis.
Martel P., Rakauskas A., Dagher J., La Rosa S., Meuwly J.Y., Roth B., Valerio M. Progres en urologie. Peer-reviewed.
[DOI][Pmid][serval:BIB_8CFD71B1DDEF]
2023
 
Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential.
Derré L., Lucca I., Cesson V., Bohner P., Crettenand F., Rodrigues-Dias S.C., Dartiguenave F., Masnada A., Teixeira-Pereira C., Benmerzoug S. et al., 2023/12/14. Journal for immunotherapy of cancer, 11 (12) pp. e008020. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_05D137E31CE9]
 
Cancer de la vessie : un suivi personnalisé pour une prise en charge efficiente [Bladder cancer : a comprehensive follow-up for an efficient and personalized care]
Bohner P., Pal M., Crettenand F., Roth B., Lucca I., 2023/11/29. Revue medicale suisse, 19 (852) pp. 2250-2253. Peer-reviewed.
[URN][Pmid][serval:BIB_E74D1ABF6507]
 
Cystectomie radicale chez les patients gériatriques. Outils de dépistage des complications postopératoires [Radical cystectomy in the geriatric population. Tools for screening postoperative complications]
Reale S., Bohner P., Crettenand F., Roth B., Lucca I., 2023/11/29. Revue medicale suisse, 19 (852) pp. 2247-2249. Peer-reviewed.
[URN][Pmid][serval:BIB_704D74C8C0BA]
 
Les décisions de politique de santé n’ont pas toujours l’effet escompté. L’exemple de l’urologie.
Valerio M., Roth B., 2023/11/29. Revue medicale suisse, 19 (852) pp. 2231-2232. Peer-reviewed.
[URN][Pmid][serval:BIB_73EDFE358858]
 
Un registre des cystectomies de la Société suisse d’urologie pour une meilleure qualité chirurgicale [A Swiss Urological Society register of cystectomies to improve surgical quality]
Pal M., Bohner P., Crettenand F., Roth B., Lucca I., 2023/11/29. Revue medicale suisse, 19 (852) pp. 2254-2256. Peer-reviewed.
[URN][Pmid][serval:BIB_4B8743AE4A68]
 
Reply to Beilstein, C.M.; Wuethrich, P.Y. Comment on "Crettenand et al. Is Continuous Wound Infiltration a Better Option for Postoperative Pain Management after Open Nephrectomy Compared to Thoracic Epidural Analgesia? J. Clin. Med. 2023, 12, 2974".
Crettenand F., Assayed-Leonardi N., Rohrer F., Martinez Carrique S., Roth B., 2023/09/12. Journal of clinical medicine, 12 (18) p. 5918. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E445824B4C21]
Differences in the Food Consumption Between Kidney Stone Formers and Nonformers in the Swiss Kidney Stone Cohort.
Legay C., Haeusermann T., Pasquier J., Chatelan A., Fuster D.G., Dhayat N., Seeger H., Ritter A., Mohebbi N., Ernandez T. et al., 2023/07. Journal of renal nutrition, 33 (4) pp. 555-565. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C2EAF4FBE5F1]
Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer.
Ahmed R., Lozano L.E., Anastasio A., Lofek S., Mastelic-Gavillet B., Navarro Rodrigo B., Nguyen S., Dartiguenave F., Rodrigues-Dias S.C., Cesson V. et al., 2023/06/08. Cancers, 15 (12) p. 3114. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4F3B91EA43E2]
 
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. Reply.
Fuster D.G., Bonny O., Roth B., 2023/05/25. The New England journal of medicine, 388 (21) pp. 2015-2016. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_09B3D12B2E2A]
 
Is Continuous Wound Infiltration a Better Option for Postoperative Pain Management after Open Nephrectomy Compared to Thoracic Epidural Analgesia?
Crettenand F., Assayed-Leonardi N., Rohrer F., Martinez Carrique S., Roth B., 2023/04/19. Journal of clinical medicine, 12 (8) p. 2974. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3BFC1AED5F20]
Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study.
Cloitre M., Valerio M., Mampuya A., Rakauskas A., Berthold D., Tawadros T., Meuwly J.Y., Heym L., Duclos F., Vallet V. et al., 2023/04/01. The British journal of radiology, 96 (1145) p. 20220803. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CB3AC2C2AFDE]
 
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Dhayat N.A., Bonny O., Roth B., Christe A., Ritter A., Mohebbi N., Faller N., Pellegrini L., Bedino G., Venzin R.M. et al., 2023/03/02. The New England journal of medicine, 388 (9) pp. 781-791. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_58067765B755]
Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study.
Rakauskas A., Peters M., Martel P., van Rossum PSN, La Rosa S., Meuwly J.Y., Roth B., Valerio M., 2023. PloS one, 18 (1) pp. e0280262. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8F7AFB48B00B]
The Swiss Kidney Stone Cohort: A Longitudinal, Multicentric, Observational Cohort to Study Course and Causes of Kidney Stone Disease in Switzerland.
Bonny O., Fuster D., Seeger H., Ernandez T., Buchkremer F., Wuerzner G., Dhayat N., Ritter A., Stoermann C., Segerer S. et al., 2023. Kidney & blood pressure research, 48 (1) pp. 194-201. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3B86FBAF801E]
 
Type 2 innate lymphoid cells are not involved in mouse bladder tumor development.
Schneider A.K., Domingos-Pereira S., Cesson V., Polak L., Fallon P.G., Zhu J., Roth B., Nardelli-Haefliger D., Derré L., 2023. Frontiers in immunology, 14 p. 1335326. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4B2B719CC888]
2022
Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies.
Domingos-Pereira S., Sathiyanadan K., Polak L., Haefliger J.A., Schmittnaegel M., Ries C.H., Jichlinski P., Roth B., Derré L., Nardelli-Haefliger D., 2022/12/21. International journal of molecular sciences, 24 (1) p. 123. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0026FCE56475]
 
Infections urinaires chez les patients avec dysfonction neurogène du bas appareil urinaire [Urinary tract infections in patients with neurogenic lower urinary tract dysfunction]
Martinez S., Roth B., Grilo N., Aleton É., 2022/11/30. Revue medicale suisse, 18 (806) pp. 2270-2273. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_376BAA170B3D]
 
Neuromodulation sacrée en urologie : indications, développements et résultats [Sacral neuromodulation in urology: Indications, advancements and outcomes]
Pal M., Assayed Leonardi N., Roth B., Grilo N., 2022/11/30. Revue medicale suisse, 18 (806) pp. 2278-2281. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_2176EAA206B9]
 
Qualité de vie ou prolongation de la vie à tout prix ? - Les priorités des patients sont souvent différentes de celles des médecins.
Benamran D., Roth B., 2022/11/30. Revue medicale suisse, 18 (806) pp. 2267-2268. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9D1CE207B77F]
 
Traitement chirurgical de l’incontinence urinaire d’effort chez l’homme [Surgical treatments for male stress urinary incontinence]
Stritt K., Reale S., Roth B., Grilo N., 2022/11/30. Revue medicale suisse, 18 (806) pp. 2282-2284. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B8B0D55DA9B9]
Is EDSS Enough to Predict Risk of Upper Urinary Tract Damage in Patients with Multiple Sclerosis?
Stritt K., Lucca I., Roth B., Grilo N., 2022/11/22. Biomedicines, 10 (12) p. 3001. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9CBFD3BA5D1C]
Intravesical Ty21a Treatment of Non-muscle-invasive Bladder Cancer Shows a Good Safety Profile.
Lucca I., Derré L., Cesson V., Bohner P., Crettenand F., Rodrigues-Dias S., Dartiguenave F., Masnada A., Texeira-Pereira C., Benmerzoug S. et al., 2022/11. European urology open science, 45 pp. 55-58. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6BF6056A37F5]
ERAS® protocol improves survival after radical cystectomy: A single-center cohort study.
Crettenand F., M'Baya O., Grilo N., Valerio M., Dartiguenave F., Cerantola Y., Roth B., Rouvé J.D., Blanc C., Lucca I., 2022/09/02. Medicine, 101 (35) pp. e30258. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DCB34BAF3D6A]
 
A longitudinal study evaluating interim assessment of neoadjuvant chemotherapy for bladder cancer.
Furrer M.A., Papa N., Luetolf S., Roth B., Cumberbatch M., Dorin Vartolomei M., Thomas B.C., Thoeny H.C., Seiler R., Thalmann G.N. et al., 2022/09. BJU international, 130 (3) pp. 306-313. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2B8C651A7F47]
Body contouring abdominoplasty for augmentation enterocystoplasty with continent cutaneous urinary diversion in an obese adolescent patient: A case report.
Meuli J.N., Grilo N., Roth B., di Summa P.G., 2022/09. Urology case reports, 44 p. 102145. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D8C34D6318BF]
 
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update.
Vartolomei M.D., Ferro M., Roth B., Teoh J.Y., Gontero P., Shariat S.F., 2022/09/01. Current opinion in urology, 32 (5) pp. 575-583. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_06BE8A16B970]
 
Re: Multiparametric Ultrasound Versus Multiparametric MRI To Diagnose Prostate Cancer (CADMUS): A Prospective, Multicentre, Paired-cohort, Confirmatory Study.
Rakauskas A., Valerio M., Roth B., 2022/08. European urology, 82 (2) pp. 239-240. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_185E142D90D8]
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.
Nguyen S., Chevalier M.F., Benmerzoug S., Cesson V., Schneider A.K., Rodrigues-Dias S.C., Dartiguenave F., Lucca I., Jichlinski P., Roth B. et al., 2022/08. Journal for immunotherapy of cancer, 10 (8) pp. e004880. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_430EBCEC5757]
 
The benefit of adopting Microultrasound in the prostate cancer imaging pathway: A lesion-by-lesion analysis: Biopsies prostatiques guidée par micro-échographie, quel bénéfice ? Une analyse lésion par lésion.
Martel P., Rakauskas A., Dagher J., La Rosa S., Meuwly J.Y., Roth B., Valerio M., 2022/06. Progres en urologie, 32 (6S1) pp. 6S26-6S32. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CB1BFE80ABF7]
Nachsorge nach Steinsanierung bei Urolithiasis [Follow-up after urolithiasis management]
Stritt K., Bosshard P., Roth B., 2022/05. Der Urologe. Ausg. A, 61 (5) pp. 500-507. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6C97F9987018]
 
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.
Benmerzoug S., Chevalier M.F., Verardo M., Nguyen S., Cesson V., Schneider A.K., Dartiguenave F., Rodrigues-Dias S.C., Lucca I., Jichlinski P. et al., 2022/05. European urology focus, 8 (3) pp. 748-751. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5DF4F82CD6A7]
 
Incontinence urinaire: un bon diagnostic comme base de traitement [Urinary incontinence: a good diagnosis as a basis for treatment]
Martinez S., Martel P., Roth B., Grilo N., 2022/01. Praxis, 110 (1) pp. 32-37. Peer-reviewed.
[DOI][Pmid][serval:BIB_26CF19D08C08]
 
The impact of stenting prior to oral chemolysis of upper urinary tract uric acid stones.
Tsaturyan A., Bosshard P., Bokova E., Bonny O., Stritt K., Roth B., 2022/01. International urology and nephrology, 54 (1) pp. 37-45. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9CB5BA7F3459]
2021
Infirmière clinicienne de centre du cancer : l’expérience du Centre de la prostate du CHUV [Cancer center clinical nurse: The experience of the CHUV Prostate Cancer Center]
Codeluppi C., Ninane F., Jolliet L., Glemarec P., Orcurto A., Rakauskas A., Tawadros T., Bosshard P., Eicher M., Herrera F. et al., 2021/12/01. Revue medicale suisse, 17 (761) pp. 2082-2085. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B3EF72B4777A]
Les biomarqueurs émergents du cancer de la prostate [Emerging biomarkers of prostate cancer]
Rakauskas A., Martel P., Roth B., Valerio M., 2021/12/01. Revue medicale suisse, 17 (761) pp. 2078-2081. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1971E9F929B2]
L’urologie du futur []
Iselin C., Roth B., 2021/12/01. Revue medicale suisse, 17 (761) pp. 2071-2072. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9CA28F841D37]
Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer Patients.
Benmerzoug S., Chevalier M.F., Villier L., Nguyen S., Cesson V., Schneider A.K., Dartiguenave F., Rodrigues-Dias S.C., Lucca I., Jichlinski P. et al., 2021/12. European urology open science, 34 pp. 79-82. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_00BEA50EB5F4]
Traitement de l’hyperplasie bénigne de la prostate - Alternatives chirurgicales à la résection transurétrale de la prostate [Benign prostatic hyperplasia treatment: Surgical alternatives to transurethral resection of the prostate]
Stritt K., Bosshard P., Roth B., Valerio M., Rakauskas A., 2021/12/01. Revue medicale suisse, 17 (761) pp. 2074-2076. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_208F61BDA3DE]
 
Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder Cancer.
Furrer M.A., Grueter T., Bosshard P., Vartolomei M.D., Kiss B., Thalmann G.N., Roth B., 2021/09. European urology focus, 7 (5) pp. 1052-1060. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AADD81BA8143]
Swiss germ-cell cancer consensus recommendations.
Beyer J., Berthold D., Bode P.K., Cathomas R., Fankhauser C.D., Fischer S., Gillessen S., Gross T., Hermanns T., Honecker F. et al., 2021/08/23. Swiss medical weekly, 151 (33-34) pp. w30023. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_632D6763E6AD]
 
Seminal Vesical Sparing Cystectomy for Bladder Cancer is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center Study.
Furrer M.A., Kiss B., Studer U.E., Wuethrich P.Y., Gahl B., Seiler R., Roth B., Bosshard P., Thomas B.C., Burkhard F.C. et al., 2021/06. The Journal of urology, 205 (6) pp. 1629-1640. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F8E351FEC10A]
Clear cell renal cancer metastasis in the contralateral ureter: a case report.
Blanc J., Roth B., 2021/05/30. Journal of medical case reports, 15 (1) p. 309. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DA91A856D0C5]
2020
En période de pénurie de ressources pour la chirurgie élective, la prévention passe au premier plan []
Roth B., Iselin C., 2020/12/02. Revue medicale suisse, 16 (717) p. 2315. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D33B29F99CE8]
La néphrolithotomie percutanée comme traitement des néphrolithiases : l’expérience du CHUV [Percutaneous nephrolithotomy (PNL) in the treatment of nephrolithiasis: the CHUV experience]
Bacchetta F., M'baya O., Bosshard P., Roth B., 2020/12/02. Revue medicale suisse, 16 (717) pp. 2325-2329. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A5BA168D87D8]
Prise en charge de la lithiase urétérale [Overview of ureteral stone management]
Bosshard P., Stritt K., Roth B., 2020/12/02. Revue medicale suisse, 16 (717) pp. 2321-2324. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1275D4DDD9C7]
Prévention de la lithiase urinaire – Résultats préliminaires de la Cohorte suisse des patients souffrant de calculs rénaux et de l’étude NOSTONE [Prevention of nephrolithiasis - Preliminary results of the Swiss Kidney Stone Cohort (SKSC) and the NOSTONE trial]
Stritt K., Bosshard P., Bonny O., Roth B., 2020/12/02. Revue medicale suisse, 16 (717) pp. 2317-2320. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F540970C083C]
Oral chemolysis is an effective, non-invasive therapy for urinary stones suspected of uric acid content.
Tsaturyan A., Bokova E., Bosshard P., Bonny O., Fuster D.G., Roth B., 2020/12. Urolithiasis, 48 (6) pp. 501-507. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E50A8E7F7606]
 
A treatment strategy to help select patients who may not need secondary intervention to remove symptomatic ureteral stones after previous stenting.
Stojkova Gafner E., Grüter T., Furrer M.A., Bosshard P., Kiss B., Vartolomei M.D., Roth B., 2020/11. World journal of urology, 38 (11) pp. 2955-2961. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D0C306B12BCF]
 
Comparison of the Diagnostic Performance of Contrast-enhanced Ultrasound with That of Contrast-enhanced Computed Tomography and Contrast-enhanced Magnetic Resonance Imaging in the Evaluation of Renal Masses: A Systematic Review and Meta-analysis.
Furrer M.A., Spycher SCJ, Büttiker S.M., Gross T., Bosshard P., Thalmann G.N., Schneider M.P., Roth B., 2020/08. European urology oncology, 3 (4) pp. 464-473. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AB6DB6D30E29]
 
TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.
Mokkapati S., Porten S.P., Narayan V.M., Lim A.H., Jayaratna I.S., Roth B., Cheng T., Navai N., Wszolek M., Melquist J. et al., 2020/06. Molecular cancer research, 18 (6) pp. 811-821. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7734923D6A75]
 
Identification of ureteral stones at reduced radiation exposure: a pilot study comparing conventional versus digital low-dosage linear slot scanning (Lodox®) radiography.
Fiechter S., Geissbühler E., Bähler A., Obmann V., Meierhans S., Exadaktylos A.K., Christe A., Thalmann G.N., Roth B., 2020/04. World journal of urology, 38 (4) pp. 1065-1071. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_60AEFCB3FC13]
 
Re: Symptomatic and Radiographic Manifestations of Kidney Stone Recurrence and Their Prediction by Risk Factors: A Prospective Cohort Study.
Roth B., 2020/03. European urology, 77 (3) p. 391. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_584674AA3E9D]
 
Evaluation of 24-h urine collection quality in the Swiss Kidney Stone Cohort-NCCR Kidney.CH
Legay C., Fuster D., Dhayat N. A., Seeger H., Ritter A., Ernandez T., Stoermann-Chopard C., Buchkremer F., Segerer S., Wuerzner G. et al., 2020. pp. 35S dans Abstracts of the cancelled 52nd Annual Meeting of the Swiss Society of Nephrology, Swiss Medical Weekly.
[WoS][serval:BIB_5F03F2F17F2E]
2019
 
Chimiothérapie néoadjuvante à base de cisplatine du cancer de la vessie : bientôt dépassée ? [Cisplatin-based chemotherapy in muscle-invasive bladder cancer: soon outdated ?]
Bosshard P., Roth B., 2019/11/27. Revue medicale suisse, 15 (673) pp. 2190-2194. Peer-reviewed.
[Pmid][serval:BIB_3BB8FA781224]
 
Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis.
Vartolomei M.D., Iwata T., Roth B., Kimura S., Mathieu R., Ferro M., Shariat S.F., Seitz C., 2019/11. World journal of urology, 37 (11) pp. 2313-2324. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_74E816F6FD49]
 
Shorter Hospital Stay and Fewer Hospitalizations in Patients With Visible Hematuria on Direct Oral Anticoagulants Compared to on Vitamin K Antagonists.
Müller M., Bosshard F., Nagler M., Roth B., Exadaktylos A.K., Sauter T.C., 2019/10. Urology, 132 pp. 101-108. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C201FEB81028]
 
Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when?
Schardt J., Roth B., Seiler R., 2019/09. World journal of urology, 37 (9) pp. 1759-1765. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F98ADB31F4D5]
 
Positive Pre-cystectomy Biopsies of the Prostatic Urethra or Bladder Neck Do Not Necessarily Preclude Orthotopic Bladder Substitution.
Roth B., Furrer M.A., Giannakis I., Vartolomei M.D., Boxler S., Wuethrich P.Y., Burkhard F.C., Thalmann G.N., Kiss B., 2019/05. The Journal of urology, 201 (5) pp. 909-915. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_73D2B9177497]
2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial.
Dhayat N.A., Faller N., Bonny O., Mohebbi N., Ritter A., Pellegrini L., Bedino G., Schönholzer C., Venzin R.M., Hüsler C. et al., 2018/12/10. BMC nephrology, 19 (1) p. 349. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_959A6A8F0038]
 
An Accurate Diagnostic Pathway Helps to Correctly Distinguish Between the Possible Causes of Acute Scrotum.
Roth B., Giannakis I., Ricklin M.E., Thalmann G.N., Exadaktylos A.K., 2018/01. Oman medical journal, 33 (1) pp. 55-60. Peer-reviewed.
[DOI][Pmid][serval:BIB_D784B84099CC]
2017
 
Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence.
Kiss B., Furrer M.A., Wuethrich P.Y., Burkhard F.C., Thalmann G.N., Roth B., 2017/12. The Journal of urology, 198 (6) pp. 1263-1268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5D84529B2720]
Characteristics and outcomes of ureteroscopic treatment in 2650 patients with impacted ureteral stones.
Legemate J.D., Wijnstok N.J., Matsuda T., Strijbos W., Erdogru T., Roth B., Kinoshita H., Palacios-Ramos J., Scarpa R.M., de la Rosette J.J., 2017/10. World journal of urology, 35 (10) pp. 1497-1506. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4EBCEEF7F6F5]
 
A low or high BMI is a risk factor for renal hematoma after extracorporeal shock wave lithotripsy for kidney stones.
Nussberger F., Roth B., Metzger T., Kiss B., Thalmann G.N., Seiler R., 2017/06. Urolithiasis, 45 (3) pp. 317-321. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F4E602AB2863]
Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis.
Roth B., Jayaratna I., Sundi D., Cheng T., Melquist J., Choi W., Porten S., Nitti G., Navai N., Wszolek M. et al., 2017/05/23. Oncotarget, 8 (21) pp. 34205-34222. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62307F91C3C7]
 
Re: Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures.
Roth B., 2017/05. European urology, 71 (5) p. 832. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D00E65C03AB2]
 
The Swiss Kidney Stone Cohort: An Observational Study to Unravel the Cause of Renal Stone Formation.
Roth B., Bonny O., Swiss Kidney Stone Cohort Investigators, 2017/02. European urology focus, 3 (1) pp. 7-9. Peer-reviewed.
[DOI][Pmid][serval:BIB_86A925F507FC]
2016
 
Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial.
Vidal A., Arnold N., Vartolomei M.D., Kiss B., Burkhard F., Thalmann G.N., Roth B., 2016/12. International journal of urology, 23 (12) pp. 992-999. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A0F4EDAAB8BF]
 
Patients with an Orthotopic Low Pressure Bladder Substitute Enjoy Long-Term Good Function.
Furrer M.A., Roth B., Kiss B., Nguyen D.P., Boxler S., Burkhard F.C., Thalmann G.N., Studer U.E., 2016/10. The Journal of urology, 196 (4) pp. 1172-1180. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F226ECE1E745]
 
Long-term results of a prospective randomized trial assessing the impact of re-adaptation of the dorsolateral peritoneal layer after extended pelvic lymph node dissection and cystectomy.
Vartolomei M.D., Kiss B., Vidal A., Burkhard F., Thalmann G.N., Roth B., 2016/04. BJU international, 117 (4) pp. 618-628. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_15252F140738]
 
Does Stepwise Voltage Ramping Protect the Kidney from Injury During Extracorporeal Shockwave Lithotripsy? Results of a Prospective Randomized Trial.
Skuginna V., Nguyen D.P., Seiler R., Kiss B., Thalmann G.N., Roth B., 2016/02. European urology, 69 (2) pp. 267-273. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D82CD48CF6FB]
Reply from Authors to the Editorial Comment.
Kiss B., Roth B., 2016/01/28. Bladder cancer, 2 (1) pp. 63-64. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3C7579E87F7B]
Pelvic Lymph Node Dissection may be Limited on the Contralateral Side in Strictly Unilateral Bladder Cancer without Compromising Oncological Radicality.
Kiss B., Paerli M., Schöndorf D., Burkhard F.C., Thalmann G.N., Roth B., 2016/01/07. Bladder cancer, 2 (1) pp. 53-59. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DECA9F138ECD]
2015
 
Optimization of Extracorporeal Shock Wave Lithotripsy Delivery Rates Achieves Excellent Outcomes for Ureteral Stones: Results of a Prospective Randomized Trial.
Nguyen D.P., Hnilicka S., Kiss B., Seiler R., Thalmann G.N., Roth B., 2015/08. The Journal of urology, 194 (2) pp. 418-423. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E933B9C674C5]
Standard cystectomy fits all: truth or myth?
Roth B., Thalmann G.N., 2015/06. Translational andrology and urology, 4 (3) pp. 254-260. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6F437A91DBBF]
 
Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer?
Kiss B., Schneider S., Thalmann G.N., Roth B., 2015/02. International journal of urology, 22 (2) pp. 158-162. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21CE2449D8C5]
2014
 
Functional multiparametric magnetic resonance imaging of the kidneys using blood oxygen level dependent and diffusion-weighted sequences.
Giannarini G., Kessler T.M., Roth B., Vermathen P., Thoeny H.C., 2014/08. The Journal of urology, 192 (2) pp. 434-439. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0A6B71517B54]
 
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
Zehnder P., Studer U.E., Daneshmand S., Birkhäuser F.D., Skinner E.C., Roth B., Miranda G., Burkhard F.C., Cai J., Skinner D.G. et al., 2014/04. BJU international, 113 (4) pp. 554-560. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_000B9DA4C5C8]
 
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Choi W., Porten S., Kim S., Willis D., Plimack E.R., Hoffman-Censits J., Roth B., Cheng T., Tran M., Lee I.L. et al., 2014/02/10. Cancer cell, 25 (2) pp. 152-165. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C137742E6EEF]
2013
 
Novel prototype sewing device, EndoSew®, for minimally invasive surgery: an extracorporeal ileal conduit construction pilot study in 10 patients.
Roth B., Birkhäuser F.D., Thalmann G.N., Zehnder P., 2013/11. BJU international, 112 (7) pp. 959-964. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A38AC78FBD3B]
 
Stricture of the afferent isoperistaltic tubular segment: a late and rare cause of bilateral dilation of the upper urinary tract after ileal bladder substitution.
Kiss B., Schöndorf D., Studer U.E., Roth B., 2013/08. Urology, 82 (2) pp. 466-470. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FB322CDE3AF5]
 
Ureteroileal strictures after urinary diversion with an ileal segment-is there a place for endourological treatment at all?
Schöndorf D., Meierhans-Ruf S., Kiss B., Giannarini G., Thalmann G.N., Studer U.E., Roth B., 2013/08. The Journal of urology, 190 (2) pp. 585-590. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1F349EA81449]
 
Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades.
Zehnder P., Studer U.E., Skinner E.C., Thalmann G.N., Miranda G., Roth B., Cai J., Birkhäuser F.D., Mitra A.P., Burkhard F.C. et al., 2013/07. BJU international, 112 (2) pp. E51-8. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1A08A57CA46F]
 
Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial.
Roth B., Birkhäuser F.D., Zehnder P., Thalmann G.N., Huwyler M., Burkhard F.C., Studer U.E., 2013/03. European urology, 63 (3) pp. 475-482. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_45CB73D58806]
 
Peri-interventional antibiotic prophylaxis only vs continuous low-dose antibiotic treatment in patients with JJ stents: a prospective randomised trial analysing the effect on urinary tract infections and stent-related symptoms.
Moltzahn F., Haeni K., Birkhäuser F.D., Roth B., Thalmann G.N., Zehnder P., 2013/02. BJU international, 111 (2) pp. 289-295. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8CEE20CF1759]
Fibroblast growth factor receptors-1 and -3 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting.
Cheng T., Roth B., Choi W., Black P.C., Dinney C., McConkey D.J., 2013. PloS one, 8 (2) pp. e57284. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FEF6BEA26094]
2012
 
Occlusion of seminal vesicles increases sexual activity in a mouse model.
Birkhäuser F.D., Schumacher C., Seiler R., de Meuron L., Zehnder P., Roth B., Wetterwald A., Thalmann G.N., Cecchini M.G., Studer U.E., 2012/11. European urology, 62 (5) pp. 855-862. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FA2249F3DB2B]
 
Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer?
Roth B., Zehnder P., Birkhäuser F.D., Burkhard F.C., Thalmann G.N., Studer U.E., 2012/05. The Journal of urology, 187 (5) pp. 1577-1582. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_92B69AFAD612]
2011
 
Lymphadenectomy for bladder cancer: indications and controversies.
Burkhard F.C., Roth B., Zehnder P., Studer U.E., 2011/11. The Urologic clinics of North America, 38 (4) pp. 397-405, v. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2C9416C4767A]
 
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
Zehnder P., Studer U.E., Skinner E.C., Dorin R.P., Cai J., Roth B., Miranda G., Birkhäuser F., Stein J., Burkhard F.C. et al., 2011/10. The Journal of urology, 186 (4) pp. 1261-1268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F6BD1FAC0791]
 
A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter.
Zehnder P., Roth B., Birkhäuser F., Schneider S., Schmutz R., Thalmann G.N., Studer U.E., 2011/04. European urology, 59 (4) pp. 637-644. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19773C109E21]
 
Irrigation of continent catheterizable ileal pouches: tap water can replace sterile solutions because it is safe, easy, and economical.
Birkhäuser F.D., Zehnder P., Roth B., Schürch L., Ochsner K., Willener R., Thalmann G.N., Burkhard F.C., Studer U.E., 2011/04. European urology, 59 (4) pp. 518-523. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0227A5B217E4]
 
Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trial.
Roth B., Birkhäuser F.D., Zehnder P., Burkhard F.C., Thalmann G.N., Studer U.E., 2011/02. European urology, 59 (2) pp. 204-210. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FACDF8A04B90]
2010
 
A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder.
Roth B., Wissmeyer M.P., Zehnder P., Birkhäuser F.D., Thalmann G.N., Krause T.M., Studer U.E., 2010/02. European urology, 57 (2) pp. 205-211. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4FC195DB805]
 
Computer aided surgery for percutaneous nephrolithotomy: Clinical requirement analysis and system design.
Oliveira-Santos T., Peterhans M., Roth B., Reyes M., Nolte L.P., Thalmann G., Weber S., 2010. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2010 pp. 442-445. Peer-reviewed.
[DOI][Pmid][serval:BIB_4B1DF9E05928]
2009
 
Noninvasive assessment of acute ureteral obstruction with diffusion-weighted MR imaging: a prospective study.
Thoeny H.C., Binser T., Roth B., Kessler T.M., Vermathen P., 2009/09. Radiology, 252 (3) pp. 721-728. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C65A1D81ABD1]
 
Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
Roth B., Studer U.E., Fowler C.J., Kessler T.M., 2009/05. The Journal of urology, 181 (5) pp. 2209-2213. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5F60FC6E7158]
2008
 
Air charged and microtip catheters cannot be used interchangeably for urethral pressure measurement: a prospective, single-blind, randomized trial.
Zehnder P., Roth B., Burkhard F.C., Kessler T.M., 2008/09. The Journal of urology, 180 (3) pp. 1013-1017. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8F6FDCEE1CC0]
1999
 
Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).
Zhao J., Richter J., Wagner U., Roth B., Schraml P., Zellweger T., Ackermann D., Schmid U., Moch H., Mihatsch M.J. et al., 1999/09/15. Cancer research, 59 (18) pp. 4658-4661. Peer-reviewed.
[WoS][Pmid][serval:BIB_372A295CB278]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University